HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Minocycline treatment and pseudotumor cerebri syndrome.

AbstractPURPOSE:
To demonstrate the association between minocycline treatment and development of the pseudotumor cerebri syndrome.
METHODS:
A retrospective study was conducted of 12 patients from five neuro-ophthalmic referral centers who developed pseudotumor cerebri syndrome after being treated with standard doses of minocycline for refractory acne vulgaris. The main outcome measures included resolution of headaches, transient visual obscurations, diplopia, papilledema, and visual fields static thresholds after withdrawal of minocycline and treatment for increased intracranial pressure.
RESULTS:
Nine (75%) of the 12 patients developed symptoms of the pseudotumor cerebri syndrome syndrome within 8 weeks of starting minocycline therapy; six were not obese. Two patients developed symptoms only after a year had elapsed because of commencement of treatment with minocycline. One patient was asymptomatic, and pseudotumor cerebri syndrome was diagnosed by finding papilledema on routine examination 1 year after minocycline was started. None of the patients developed recurrences for at least 1 year after the discontinuation of minocycline and treatment for increased intracranial pressure, but three (25%) of the 12 patients had substantial residual visual field loss.
CONCLUSION:
Minocycline is a cause or precipitating factor in pseudotumor cerebri syndrome. Although most patients have prominent symptoms and are diagnosed promptly, others are asymptomatic and may have optic disk edema for a long period of time before diagnosis. Withdrawal of minocycline and treatment for increased intracranial pressure lead to resolution of the pseudotumor cerebri syndrome, but visual field loss may persist.
AuthorsA M Chiu, W L Chuenkongkaew, W T Cornblath, J D Trobe, K B Digre, S A Dotan, K H Musson, E R Eggenberger
JournalAmerican journal of ophthalmology (Am J Ophthalmol) Vol. 126 Issue 1 Pg. 116-21 (Jul 1998) ISSN: 0002-9394 [Print] United States
PMID9683157 (Publication Type: Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • Minocycline
Topics
  • Acne Vulgaris (drug therapy)
  • Adolescent
  • Adult
  • Anti-Bacterial Agents (adverse effects)
  • Diplopia (chemically induced)
  • Female
  • Follow-Up Studies
  • Headache (chemically induced)
  • Humans
  • Intracranial Pressure
  • Minocycline (adverse effects)
  • Papilledema (chemically induced)
  • Pseudotumor Cerebri (chemically induced)
  • Retrospective Studies
  • Syndrome
  • Vision Disorders (chemically induced)
  • Visual Acuity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: